Exploring the Safety and Effects of COVID-19 Vaccination in Patients with Autoimmune Disease

Authors

  • Kirttna Solai Vairavan
  • Loh Teng-Hern Tan
  • Jodi Woan Fei Law
  • Priyia Pusparajah
  • Vengadesh Letchumanan

DOI:

https://doi.org/10.36877/pmmb.a0000277

Abstract

The COVID-19 pandemic has quickly become the most significant public health phenomenon, effectively eclipsing the H1N1 and Ebola crises that came before it. It can spread rapidly and has caused the death and disability of many worldwide. Vaccines are our most effective line of defense against the rapidly spreading and mutating virion. Still, there is significant vaccine hesitancy among those with autoimmune conditions who fear the vaccine may cause them more harm than good. This scoping review explores the safety, outcomes, and effects of COVID-19 vaccines in autoimmune patients. Online databases; Pubmed, Ovid Medline, and Scopus were used to search published literature evaluating the effectiveness and side effects of COVID-19 vaccines in patients with autoimmune conditions. The search results were limited to 4 distinct autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, psoriasis, and myasthenia gravis). Thirty-seven studies were retrieved and assessed on the safety, effects, and outcomes of COVID-19 vaccination in patients with the chosen autoimmune conditions. Overall, the risk of flares and the development of severe side effects after vaccination was low. Most autoimmune patients showed a good antibody response to vaccination, especially after the second dose. This review provides a favorable impact of vaccination in patients with autoimmune conditions.

Downloads

Published

2022-11-16

How to Cite

Vairavan, K. S., Tan, L. T.-H., Law, J. W. F., Pusparajah, P., & Letchumanan, V. (2022). Exploring the Safety and Effects of COVID-19 Vaccination in Patients with Autoimmune Disease. Progress In Microbes & Molecular Biology, 5(1). https://doi.org/10.36877/pmmb.a0000277

Issue

Vol. 5 No. 1 (2022)

Section

Review Articles

License

Copyright (c) 2022 Kirttna Solai Vairavan, Loh Teng-Hern Tan, Jodi Woan Fei Law, Priyia Pusparajah, Vengadesh Letchumanan

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Author(s) shall retain the copyright of their work and grant the Journal/Publisher right for the first publication with the work simultaneously licensed under:

Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows for the copying, distribution and transmission of the work, provided the correct attribution of the original creator is stated. Adaptation and remixing are also permitted.

 

This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types for non-commercial purposes.

The author(s) permits HH Publisher to publish this article that has not been submitted elsewhere.

Abstract viewed = 436 times
PDF downloaded = 426 times